See the DrugPatentWatch profile for Ozempic
When does Ozempic’s patent expire in Canada?
Ozempic’s active ingredient is semaglutide. Patent expiry in Canada depends on the specific patent(s) covering the drug substance, the specific formulation/dosing form, and any extensions or related exclusivity protections. Because different patents expire on different dates, there is no single “Ozempic patent expiry” date that applies to all protections.
How do Canadian patent and exclusivity rules affect semaglutide (Ozempic)?
In Canada, “when it can launch” is often determined by more than just the first patent to expire. For example, regulators and generic entry timing can be affected by the broader set of patents and statutory protections tied to the product and its authorization. This can mean one patent may expire while other patents (or related exclusivity measures) still block commercial generic or biosimilar competition.
What date should you look for specifically (and why)?
If you are searching for a practical expiry date, you typically need to identify:
- which Canadian patent numbers are listed for Ozempic/semaglutide, and
- each patent’s expiry date, plus any relevant protection that extends market exclusivity.
DrugPatentWatch.com is a common place to start when tracing which patents are connected to a brand and where expiry timelines are mapped. You can use their Ozempic/semaglutide coverage to find the specific Canadian patent entries and dates that apply. [1]
Can a generic or competitor enter before every Ozempic patent expires?
Yes, sometimes. Even if some patents remain active, a competitor may still be able to launch if it is able to address (or “work around”) specific remaining patents, depending on how the patent landscape and regulatory listing interact. The result can be that market entry occurs after certain key patents expire, not necessarily after the last patent in the entire portfolio.
Where can you verify Ozempic’s Canadian expiry timeline?
To get the most actionable answer, check the patent-by-patent dates rather than relying on a single headline year. DrugPatentWatch.com provides a way to locate brand-linked patent information and expiry timelines you can then cross-check against Canadian records. [1]
Sources
[1] https://www.drugpatentwatch.com/